QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web

Wednesday, October 31, 2007 General News J E 4
VENLO, The Netherlands, Oct. 30 In conjunctionwith QIAGEN's Third Quarter 2007 Earnings release, you are invited to listento its conference call which will be broadcast live over the Internet onTuesday, November 6, 2007 at 9:30 a.m. EST, with Peer M. Schatz, President andChief Executive Officer and Roland Sackers, Chief Financial Officer.

QIAGEN N.V., a Netherlands holding company, is a leading provider ofinnovative technologies and products for pre-analytical sample preparation andmolecular diagnostics solutions. QIAGEN has developed a comprehensiveportfolio of more than 500 proprietary, consumable products and automatedsolutions for sample collection, and nucleic acid and protein handling,separation, and purification. QIAGEN also supplies diagnostic kits, tests, andassays for human and veterinary molecular diagnostics. The company's productsare sold to academic research markets, and to leading pharmaceutical andbiotechnology companies; as well as to diagnostics laboratories. QIAGEN alsoprovides purification and testing solutions to applied testing markets: suchas forensics, animal or food testing, and pharmaceutical process control.

QIAGEN employs more than 2,600 people worldwide. QIAGEN products are soldthrough a dedicated sales force and a global network of distributors in morethan 40 countries.

Further information about QIAGEN can be found at

(Minimum Requirements to listen to broadcast: The RealPlayer software,downloadable free from, or TheWindows Media Player, downloadable free from and at least a14.4Kbps connection to the Internet. If you experience problems listening tothe broadcast, send an email to QIAGEN N.V. -- Third Quarter 2007 Earnings Announcement When: Tuesday, November 6, 2007 at 9:30 a.m. EST Where: How: Live over the Internet -- Simply log on to the Web at the address above. The corresponding presentation slides are available to download in the investor relations section of QIAGEN's website at: Contact: Andreas Marathovouniotis, Russo Partners, 212-845-4253



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
CryoCor to Present at CIBC World Markets 18th Annu...
Zicam(R) Cold Remedy to Sponsor ING New York City ...